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Methods and materials. A single patient with stage IV MF with 14 symptomatic plaques and tumors underwent low-dose (8Gy in
two fractions) local radiotherapy.
Results. Complete response has been achieved for all lesions (100%). After a median of 18.1 months of follow-up (39-1 months)
no lesions needed re-irradiation.
Conclusions. In our experience low-dose involved ﬁeld radiotherapy has proved to be a very efﬁcient, tolerable and cost effective
approach as a palliative treatment in CTCL lesions.
http://dx.doi.org/10.1016/j.rpor.2013.03.337
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Introduction.BoneMarrowTransplantwith conventionalmyeloablative conditioninghashighmorbidity andmortality, particularly
in fragile patients. These patients may be candidates for a transplant with a non-myeloablative conditioning regime.
Objectives. Retrospective analysis of the feasibility and toxicity of the treatmentwithTBI to 2Gydosenon-myeloablative allogeneic
bone marrow transplant.
Patients and methods. Retrospective study, non randomised, from 2009 to 2012 in patients treated with TBI with 2Gy as part of
the treatment myeloablative allogeneic bone marrow transplant. Inclusion criteria: (1) 50 years and older and not candidates
to myeloablative standar transplant. (2) Tandem transplant, allotransplantation followed by allogenic autotransplantation in a
short period of time. We recruited 6 women and 4 men, aged 43–56 years old, 2 with acute lymphoblastic leukemia, one with
acute myeloid leukemia, 1 with chronic lymphoblastic leukemia, three with multiple myeloma, 1 with myelodysplastic syndrome
and 1 with aplastic anemia. Scheme Conditioning: 2Gy doses in a single session, premedication with 1mg/kg and ondansetron
8mg prednisone/8h at least ½h before TBI. The technique is similar to myeloablative TBI.
Results. No patient had associated toxicity conditioning, 5 relapses, 2 deaths and 3 are still alive and healthy. One underwent
BMT 2Gy and subsequently with INT 5Gy with implant loss and died.
Conclusion. This is a simple technique, with no conditioning linked toxicity that could be used in patients for whom standard
patterns are not feasible.
http://dx.doi.org/10.1016/j.rpor.2013.03.338
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Introduction. Primary lymphomas of the ocular adnexa (OL) constitute 7% of extranodal lymphomas. The most common symp-
toms are a growing mass followed by pain. Low grade histology is most frequent. Intraocular lymphoma (IOL) represent <1% of
lymphomas and its associated with CNS lesions. Bilateral involvement occurs in almost 80% and usually appears as a refractory
non-speciﬁc uveitis associated with campimetric deﬁcit; its often a high grade histology, being commonly diffuse large B cell
lymphoma.
Objective. To report four cases of OL and IOL and their multidisciplinary treatment.
Cases report. Three cases of OL inwomen between 58 and 90 year-old, one primary and two secondary tomarginal zone and follicle
lymphoma. The diagnosis was made by biopsy of low grade lymphoma. One case of IOL in a 69 year-old man with primary CNS
lymphoma. The diagnosis was made by vitreus aspiration of a diffuse B cell lymphoma. They were presented with a growing
mass vision changes of a non-speciﬁc uveitis of 10–24 months of duration. None of the patients received chemotherapy. In two of
the OL cases a gross total resection was performed followed by radiation therapy to the tumoral bed and the other cases received
irradiation of both orbits, TD: 30Gy/1.8Gy.
Results. All patients, the MRI revealed no residual tumor with complete resolution. The patients are in follow-up, asymptomatic
and free recurrence.
Conclusions. The literature suggest that OL can be treated with radiotherapy, reaching local control >95% with good prognostic.
The IOL treatment establishes initial chemotherapy followed by irradiation, they have worse prognostic; ocular recurrence are
common and most patients developed CNS disease within 14–84 With either 30–36Gy and standard fractionation, has been
associated a lower ocular relapse rate, and the effect on ocular disease control suggests that they have a potential role in survival.
http://dx.doi.org/10.1016/j.rpor.2013.03.339
